[1]黄 婷,徐 燕,史庆星.2型糖尿病患者糖化血红蛋白与空腹血糖、血脂检测的关系分析[J].医学信息,2022,35(18):147-149.[doi:10.3969/j.issn.1006-1959.2022.18.041]
　HUANG Ting,XU Yan,SHI Qing-xing.Analysis of the Relationship Between Glycosylated Hemoglobin and Fasting Blood Glucose,Blood Lipids in Patients with Type 2 Diabetes Mellitus[J].Journal of Medical Information,2022,35(18):147-149.[doi:10.3969/j.issn.1006-1959.2022.18.041]
点击复制

2型糖尿病患者糖化血红蛋白与空腹血糖、血脂检测的关系分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年18期
页码:
147-149
栏目:
诊疗技术
出版日期:
2022-09-15

文章信息/Info

Title:
Analysis of the Relationship Between Glycosylated Hemoglobin and Fasting Blood Glucose,Blood Lipids in Patients with Type 2 Diabetes Mellitus
文章编号:
1006-1959（2022）18-0147-03
作者:
黄 婷; 徐 燕; 史庆星
（溧阳市人民医院检验科，江苏 溧阳 213300）
Author(s):
HUANG Ting; XU Yan; SHI Qing-xing
(Laboratory Department of Liyang People’s Hospital,Liyang 213300,Jiangsu,China)
关键词:
2型糖尿病; 糖化血红蛋白; 空腹血糖; 血脂检测
Keywords:
Type 2 diabetes mellitus; Glycosylated hemoglobin; Fasting blood glucose; Blood lipid testing
分类号:
R587.1
DOI:
10.3969/j.issn.1006-1959.2022.18.041
文献标志码:
A
摘要:
目的 分析2型糖尿病（T2DM）患者糖化血红蛋白（HbA1c）与空腹血糖（FBG）、血脂检测的关系。方法 选择本院2020年9月-2021年9月收治的T2DM患者48例设作研究组，另同期健康状况正常者48例设作对照组，测定两组HbA1c、FBG、甘油三脂（TG）、总胆固醇（TC）、低密度脂蛋白（LDL）、高密度脂蛋白（HDL）水平。比较两组一般资料，Logistic回归分析T2DM发病的相关影响因素，Pearson法分析研究组HbA1c与FBG、TG、TC、LDL、HDL的相关性。结果 研究组HbA1c、FBG、TG、TC、LDL水平较对照组高，HDL较对照组低，差异有统计学意义（P＜0.05）；HbA1c、FBG、TG、TC、LDL水平过高是T2DM发病的独立危险因素（OR=1.042、2.280、1.844、1.868、2.054，P＜0.05）；研究组HbA1c与FBG、TG、TC、LDL成正相关（r=0.238、0.128、0.252、0.527，P＜0.05），与HDL成负相关（r=-0.174，P＜0.05）。结论 T2DM患者HbA1c与FBG、血脂水平密切相关，有助于T2DM的诊断。
Abstract:
Objective To analyze the relationship between glycosylated hemoglobin (HbA1c) and fasting blood glucose (FBG) and blood lipid in patients with type 2 diabetes mellitus (T2DM).Methods A total of 48 patients with T2DM admitted to our hospital from September 2020 to September 2021 were selected as the study group, and 48 patients with normal health status were selected as the control group. The levels of HbA1c, FBG, triglyceride (TG), total cholesterol (TC), low density lipoprotein (LDL) and high density lipoprotein (HDL) were measured in the two groups. The general data of the two groups were compared. Logistic regression was used to analyze the related factors of T2DM. Pearson method was used to analyze the correlation between HbA1c and FBG, TG, TC, LDL, HDL in the study group.Results The levels of HbA1c, FBG, TG, TC and LDL in the study group were higher than those in the control group, and HDL was lower than that in the control group (P<0.05). High levels of HbA1c, FBG, TG, TC and LDL were independent risk factors for T2DM (OR=1.042, 2.280, 1.844, 1.868, 2.054, P<0.05). HbA1c in the study group was positively correlated with FBG, TG, TC and LDL (r=0.238,0.128,0.252,0.527, P<0.05), and negatively correlated with HDL (r=-0.174, P<0.05).Conclusion HbA1c is closely related to FBG and blood lipid levels in patients with T2DM, which is helpful for the diagnosis of T2DM.

参考文献/References:

[1]Fangnian W,Hongsheng L,Blanton WP,et al.Brd2 disruption in mice causes severe obesity without Type 2 diabetes[J].The Biochemical Journal,2019,4(12):12-13.[2]Vallée Marcotte B,Guénard F,Marquis J,et al.Genetic Risk Score in Diabetes Associated With Chronic Pancreatitis Versus Type 2 Diabetes Mellitus[J].Journal of Bone and Mineral Metabolism,2019,15(2):S21-S22.[3]Dennis JM.Precision Medicine in Type 2 Diabetes: Using Individualized Prediction Models to Optimize Selection of Treatment[J].Diabetes,2020,69(10):1351-1353.[4]Qiu M,Liu SY,Gu JS,et al.Do reductions in risk of cardiorenal events with SGLT2 inhibitors in type 2 diabetes vary with baseline characteristics? A meta-analysis[J].Endocrine,2020,14(2):189-195.[5]Group I.Global Guideline for Type 2 Diabetes - ScienceDirect[J].Diabetes Research and Clinical Practice,2014,104(1):1-52.[6]Mencke R,Vaart A,Pasch A,et al.Serum calcification propensity is associated with HbA1c in type 2 diabetes mellitus[J].BMJ Open Diabetes Research & Care,2021,9(1):335-336.[7]Tahir A,Martinez PJ,Ahmad F,et al.An evaluation of lipid profile and pro-inflammatory cytokines as determinants of cardiovascular disease in those with diabetes:A study on a Mexican American cohort[J].Scientific Reports,2021,11(1):773-776.[8]Richardson TG,Wang Q,Sanderson E,et al.Effects of apolipoprotein B on lifespan and risks of major diseases including type 2 diabetes: a mendelian randomisation analysis using outcomes in first-degree relatives[J].The Lancet Healthy Longevity,2021,22(2):135-137.[9]Kn A,Tjbb C,Im A,et al.Variation between general practitioners in type 2 diabetes processes of care[J].Primary Care Diabetes,2021,15(3):495-501.[10]Kao YC,Chen TH,Liu CH,et al.Similar major cardiovascular outcomes between pure statin and ezetimibe-statin in comparable intensity for type 2 diabetes with extremely atherosclerotic risks[J].Scientific Reports,2021,11(1):545-549.[11]Sara S,Flores-Guerrero JL,Kieneker LM,et al.HDL particle subspecies and their association with incident type 2 diabetes: the PREVEND study[J].The Journal of Clinical Endocrinology & Metabolism,2021,16(32):6360-6363.[12]贾童林,唐琦,陆菊明,等.应用瞬感扫描式葡萄糖监测系统观察阿卡波糖对2型糖尿病患者血糖波动的影响[J].中国糖尿病杂志,2019,27(7):532-538[13]陈一佳,武鸣,苏健,等.江苏省两城市35岁及以上2型糖尿病患者缺血性心血管病10年发病风险评估[J].中华预防医学杂志,2019,53(2):5-8.[14]刘云坤,徐欣,周学东.人体微生物组在辅助2型糖尿病诊疗中的潜在应用[J].华西口腔医学杂志,2019,37(5):106-112.[15]王文鑫,刘传鑫,张丛,等.基于LC-MS和分子对接策略分析金芪降糖片治疗2型糖尿病的药效物质基础[J].中国实验方剂学杂志,2020,26(3):133-144.[16]Feng RF,Liu YL,Xu Q,et al.Diabetes onset at an earlier age and high HbA1c levels as risk factors of diabetic retinopathy[J].International Journal of Ophthalmology,2021,14(2):269-276.[17]Ma J,Zhang B,Hou J,et al.Efficacy and Safety of Once Weekly Dulaglutide in East Asian Patients with Type 2 Diabetes: Subgroup Analysis by Potential Influential Factors[J].Diabetes Therapy,2020,293(4):1151-1162.[18]Pscherer S,Anderten H,Pfohl M,et al.Titration of insulin glargine 100U/mL when added to oral antidiabetic drugs in patients with type 2 diabetes: results of the TOP-1 real-world study[J].Acta Diabetologica,2020,57(1):89-99.[19]Salmani Mood M,Yavari Z,Bahrami Taghanaki H,et al.The effect of acupressure on fasting blood glucose, glycosylated hemoglobin and stress in patients with type 2 diabetes[J].Complement Ther Clin Pract,2021,43:101393.[20]徐佳,洪阿娜,梁金莲.血糖,血脂及糖化血红蛋白检测对中老年2型糖尿病患者诊断价值研究[J].临床军医杂志,2019,47(9):3-6.

相似文献/References:

[1]黄德斌,章臻翊,章 婷,等.2型糖尿病患者亚临床甲状腺功能减退与白蛋白尿的关系研究[J].医学信息,2018,31(02):88.[doi:10.3969/j.issn.1006-1959.2018.02.030]
　HUANG De-bin,ZHANG Zhen-yi,ZHANG Ting,et al.Relationship between Subclinical Hypothyroidism and Albuminuria in Patients with Type 2 Diabetes Mellitus[J].Journal of Medical Information,2018,31(18):88.[doi:10.3969/j.issn.1006-1959.2018.02.030]
[2]樊金莲,农 媛,肖 海.糖化血红蛋白、血同型半胱氨酸在非糖尿病性急性脑梗死患者中的水平变化及其临床意义[J].医学信息,2018,31(02):94.[doi:10.3969/j.issn.1006-1959.2018.02.032]
　FAN Jin-lian,NONG Yuan,XIAO Hai.The Level Changes and Clinical Significance of Glycosylated Hemoglobin and Blood Homocysteine in Patients with Non-Diabetic Acute Cerebral Infarction[J].Journal of Medical Information,2018,31(18):94.[doi:10.3969/j.issn.1006-1959.2018.02.032]
[3]邓婷婷,王亚洲,张 红.口福怡稻治疗2型糖尿病的临床效果研究[J].医学信息,2018,31(03):116.[doi:10.3969/j.issn.1006-1959.2018.03.039]
　DENG Ting-ting,WANG Ya-zhou,ZHANG Hong.Clinical Study on the Treatment of Type 2 Diabetes Mellitus with Kou Fuyi Dao[J].Journal of Medical Information,2018,31(18):116.[doi:10.3969/j.issn.1006-1959.2018.03.039]
[4]曹岚,侯瑞田,王福慧,等.Lp-PLA2血小板相关因子与2型糖尿病合并高血压病的 相关性研究[J].医学信息,2018,31(05):3.[doi:10.3969/j.issn.1006-1959.2018.05.002]
　CAO Lan,HOU Rui-tian,WANG Fu-hui,et al.Study on the Correlation between Lp-PLA2 Platelet-associated Factors and Type 2 Diabetes Mellitus Complicated with Hypertension[J].Journal of Medical Information,2018,31(18):3.[doi:10.3969/j.issn.1006-1959.2018.05.002]
[5]靳雪芹,邓正聪.代谢综合征与肿瘤关系的研究进展[J].医学信息,2018,31(05):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
　JIN Xue-qin,DENG Zheng-cong.Research Progress on the Relationship between Metabolic Syndrome and Tumor[J].Journal of Medical Information,2018,31(18):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
[6]刘爱君.糖化血红蛋白测定在糖尿病诊断中的应用价值分析[J].医学信息,2018,31(08):161.[doi:10.3969/j.issn.1006-1959.2018.08.057]
　LIU Ai-jun.Analysis of the Value of Determination of Glycosylated Hemoglobin in the Diagnosis of Diabetes Mellitus[J].Journal of Medical Information,2018,31(18):161.[doi:10.3969/j.issn.1006-1959.2018.08.057]
[7]刘 洪.地特胰岛素或甘精胰岛素联合使用口服药物治疗2型糖尿病疗效及对体重的影响分析[J].医学信息,2018,31(09):135.[doi:10.3969/j.issn.1006-1959.2018.09.042]
　LIU Hong.Effect of Insulin Detemir or Insulin Glargine Combined with Oral Medication on Type 2 Diabetes Mellitus and its Influence on Body Weight[J].Journal of Medical Information,2018,31(18):135.[doi:10.3969/j.issn.1006-1959.2018.09.042]
[8]杨锦龙,刘 欢,吕秋菊,等.非糖尿病患者糖化血红蛋白和胰岛素抵抗与 冠状动脉病变程度的相关性研究[J].医学信息,2018,31(10):93.[doi:10.3969/j.issn.1006-1959.2018.10.028]
　YANG Jin-long,LIU Huan,LV Qiu-ju,et al.Correlation between Glycosylated Hemoglobin and Insulin Resistance and Severity of Coronary Artery Disease in Non-diabetic Patients[J].Journal of Medical Information,2018,31(18):93.[doi:10.3969/j.issn.1006-1959.2018.10.028]
[9]郭云飞,王亚柱,刘 超,等.血浆致动脉硬化指数与冠心病合并2型糖尿病的相关性分析[J].医学信息,2022,35(09):108.[doi:10.3969/j.issn.1006-1959.2022.09.027]
　GUO Yun-fei,WANG Ya-zhu,LIU Chao,et al.Correlation Between Plasma Arteriosclerosis Index and Coronary Heart Disease Complicated with Type 2 Diabetes Mellitus[J].Journal of Medical Information,2022,35(18):108.[doi:10.3969/j.issn.1006-1959.2022.09.027]
[10]徐晨曦.达格列净联合DPP-4抑制剂与二甲双胍对血糖控制不佳2型糖尿病患者血糖及脂代谢的影响[J].医学信息,2022,35(09):165.[doi:10.3969/j.issn.1006-1959.2022.09.042]
　XU Chen-xi.Effects of Daglitazone Combined with DPP-4 Inhibitor and Metformin on Blood Glucose and Lipid Metabolism in Patients with Type 2 Diabetes Mellitus with Poor Glycemic Control[J].Journal of Medical Information,2022,35(18):165.[doi:10.3969/j.issn.1006-1959.2022.09.042]
[11]叶 军,邹玲玲,戴 武,等.社区慢病管理对2型糖尿病患者糖化血红蛋白的影响[J].医学信息,2018,31(19):99.[doi:10.3969/j.issn.1006-1959.2018.19.029]
　YE Jun,ZOU Ling-ling,DAI Wu,et al.Effects of Community Chronic Disease Management on Glycosylated Hemoglobin in Patients with Type 2 Diabetes Mellitus[J].Journal of Medical Information,2018,31(18):99.[doi:10.3969/j.issn.1006-1959.2018.19.029]
[12]廖 霜.二甲双胍联合沙格列汀或格列美脲对新诊断合并腹型肥胖的2型糖尿病患者临床疗效对比[J].医学信息,2018,31(24):70.[doi:10.3969/j.issn.1006-1959.2018.24.018]
　LIAO Shuang.Comparison of Clinical Efficacy of Metformin Combined with Salglutin or Glimepiride in Newly Diagnosed Type 2 Diabetic Patients with Abdominal Obesity[J].Journal of Medical Information,2018,31(18):70.[doi:10.3969/j.issn.1006-1959.2018.24.018]
[13]王艳荣.血清胆红素、糖化血红蛋白联合血脂检验在2型糖尿病合并 冠心病诊断中的应用价值[J].医学信息,2019,32(16):165.[doi:10.3969/j.issn.1006-1959.2019.16.056]
　WANG Yan-rong.Value of Serum Bilirubin and Glycosylated Hemoglobin Combined with Blood Lipid Test in the Diagnosis of Type 2 Diabetes Mellitus Complicated with Coronary Heart Disease[J].Journal of Medical Information,2019,32(18):165.[doi:10.3969/j.issn.1006-1959.2019.16.056]
[14]姜 博,刘 艳.FPG和HbA1c对急性脑梗死合并2型糖尿病患者静脉溶栓效果的影响[J].医学信息,2020,33(08):118.[doi:10.3969/j.issn.1006-1959.2020.08.037]
　JIANG Bo,LIU Yan.Effects of FPG and HbA1c on the Efficacy of Intravenous Thrombolysis in Patients with Acute Cerebral Infarction and Type 2 Diabetes[J].Journal of Medical Information,2020,33(18):118.[doi:10.3969/j.issn.1006-1959.2020.08.037]
[15]汤 珂,秦月兰,赵琼玲,等.2型糖尿病患者合并焦虑抑郁的发生现状及影响因素研究[J].医学信息,2021,34(23):54.[doi:10.3969/j.issn.1006-1959.2021.23.015]
　TANG Ke,QIN Yue-lan,ZHAO Qiong-ling,et al.Study on the Current Status and Influencing Factors of Anxiety and Depression in Patients with Type 2 Diabetes[J].Journal of Medical Information,2021,34(18):54.[doi:10.3969/j.issn.1006-1959.2021.23.015]
[16]赵祥雷,江菊青,林立群.糖化血红蛋白与血脂检测在2型糖尿病患者中的价值[J].医学信息,2023,36(24):148.[doi:10.3969/j.issn.1006-1959.2023.24.034]
　ZHAO Xiang-lei,JIANG Ju-qing,LIN Li-qun.Value of Glycosylated Hemoglobin and Blood Lipid Detection in Patients with Type 2 Diabetes Mellitus[J].Journal of Medical Information,2023,36(18):148.[doi:10.3969/j.issn.1006-1959.2023.24.034]

更新日期/Last Update: 1900-01-01